CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Jul 11, 11:30

Novavax (NVAX) Could Be 32% Undervalued As Russell Index Exit Reshapes The View

Novavax Inc
Webhose 2026 Jul 11, 09:57

Head to Head Contrast: Basilea Pharmaceutica (OTCMKTS:BPMUF) and Novavax (NASDAQ:NVAX) - Stock Observer

Novavax Inc
Webhose 2026 Jul 10, 18:20

Novavax Target of Unusually Large Options Trading (NASDAQ:NVAX)

Novavax Inc
Webhose 2026 Jul 10, 05:15

Novavax (NVAX) Leaves Russell Growth Indexes, Is The 32% Undervaluation Case Convincing?

Novavax Inc
Webhose 2026 Jul 10, 03:24

Novavax (NVAX) Dropped From Major Russell Growth Indices And Why It Matters

Novavax Inc
Webhose 2026 Jul 09, 10:57

Zacks Research Predicts Novavax's Q1 Earnings (NASDAQ:NVAX)

Novavax Inc
Webhose 2026 Jul 08, 13:30

Zacks Research Predicts Novavax's Q3 Earnings (NASDAQ:NVAX) - Zolmax

Novavax Inc
Webhose 2026 Jul 08, 10:48

Novavax (NASDAQ:NVAX) Raised to Strong-Buy at Zacks Research - Zolmax

Novavax Inc
Webhose 2026 Jul 06, 09:01

Novavax (NASDAQ:NVAX) Stock Price Down 5.5% - What's Next? - Daily Political

Novavax Inc
Webhose 2026 Jul 05, 09:21

SG Americas Securities LLC Cuts Holdings in Novavax, Inc. $NVAX

Novavax Inc
Webhose 2026 Jul 03, 23:23

Novavax (NVAX) After Russell Index Exits Is The Undervalued View Already Priced In

Novavax Inc
Webhose 2026 Jul 01, 08:14

Assenagon Asset Management S.A. Makes New Investment in Novavax, Inc. $NVAX

Novavax Inc
Webhose 2026 Jun 27, 05:21

Novavax (NASDAQ:NVAX) Trading Down 6.9% - Time to Sell? - Daily Political

Novavax Inc
Webhose 2026 Jun 26, 22:14

How Investors May Respond To Novavax (NVAX) Shareholder Revolt Over Pay And Board Governance

Novavax Inc
Webhose 2026 Jun 24, 14:04

Novavax (NVAX) Faces Shareholder Backlash Despite AGM Resolutions Approval

Novavax Inc

Novavax news

Latest news

Info

Spread

0.05

Spread (%)

0.6337 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1295772288

Shares Outstanding

164438119

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-0.54

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)

Latest Education Articles

Trustpilot